San Francisco, CA, United States of America

Kathy R Bailey

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: University of California. Active years: 2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kathy R Bailey. Retrieved from https://idiyas.com/inventor/kathy-r-bailey

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Kathy R Bailey in Age-Related Macular Degeneration

Introduction

Kathy R Bailey is an accomplished inventor based in San Francisco, CA. She has made significant contributions to the field of ophthalmology, particularly in the treatment of age-related macular degeneration. With a total of 2 patents, her work focuses on innovative methods to enhance visual function and address retinal health.

Latest Patents

Kathy's latest patents include groundbreaking inventions aimed at improving the treatment of age-related macular degeneration. The first patent, titled "Methods to increase reverse cholesterol transport in the retinal pigment epithelium (RPE) and Bruch's membrane (BM)," addresses the treatment of this condition by regulating pathogenic mechanisms similar to those found in atherosclerosis. This invention utilizes compositions that increase reverse cholesterol transport as therapeutic targets for age-related macular degeneration. A specific embodiment of this patent involves reducing the lipid content of the retinal pigment epithelium and/or Bruch's membrane by delivering Apolipoprotein A1, particularly a mimetic peptide.

The second patent, "Treatment for dark adaptation," also targets age-related macular degeneration and aims to improve visual function in individuals with impaired dark adaptation. Similar to her first patent, this invention employs compositions that enhance reverse cholesterol transport as therapeutic targets. The lipid content of the retinal pigment epithelium and/or Bruch's membrane is again reduced through the delivery of Apolipoprotein A1, particularly a mimetic peptide.

Career Highlights

Kathy R Bailey is affiliated with the University of California, where she continues to advance her research and innovations in the field of ophthalmology. Her work has garnered attention for its potential to significantly improve the quality of life for individuals suffering from age-related visual impairments.

Collaborations

Kathy has collaborated with notable colleagues, including Keith G Duncan and Brian Y Ishida, to further her research and develop her innovative solutions.

Conclusion

Kathy R Bailey's contributions to the treatment of age-related macular degeneration through her innovative patents highlight her dedication to improving visual health. Her work exemplifies the impact of research and innovation in addressing critical health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…